Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
NeuroVive Pharmaceutical AB Year End Report January - December 2019 2020-02-19 16:08
NeuroVive Announces Settlement in Dispute With CicloMulsion AG 2019-12-16 18:33
NeuroVive Pharmaceutical AB Interim Report January - September 2019 2019-11-20 16:38
NeuroVive Pharmaceutical AB Interim Report January - June 2019 2019-08-21 15:24
NeuroVive's IND for Clinical Development of NeuroSTAT Approved by FDA 2019-05-10 15:05
NeuroVive Pharmaceutical AB Publishes 2018 Annual Report 2019-03-25 17:58
NeuroVive Receives Vinnova Funding to Support Development of NV354, a Novel Treatment for Genetic Mitochondrial Disorders 2018-11-15 19:37
NeuroVive Reports First NeuroSTAT Clinical Efficacy Signal in TBI 2018-10-04 15:43
NeuroVive Reports Promising Progress in its Clinical Project for Genetic Mitochondrial Diseases, KL1333 2017-12-11 18:56
Amended Number of Shares and Votes in NeuroVive Pharmaceutical AB (publ) 2017-11-30 19:51
NeuroVive's Genetic Mitochondrial Disease Program NVP015 Reaches Significant Milestone 2017-11-30 16:26
NeuroVive Presents TBI Clinical Study Results at Nordic Neurotrauma Conference 2017-11-15 16:48
NeuroVive Signs Collaboration Agreement With University of Florida for TBI Biomarker Development 2017-10-31 16:32
NeuroVive and Lund University Collaboration Receives Grant for Liver Cancer Research 2017-10-18 15:05
NeuroVive's Collaborator, the Children's Hospital of Philadelphia Awarded NIH Grant to Study NVP015 Against Chemical Threats 2017-10-06 05:44
NeuroVive Receives Research Grant From Vinnova for Development of the NVP015 Genetic Mitochondrial Disease Project 2017-06-01 19:52
NeuroVive Pharmaceutical AB Interim Report January - March 2017 2017-05-18 15:18
NeuroVive in-licenses a Genetic Mitochondrial Disease Clinical Stage Project From Yungjin Pharm 2017-05-02 11:51
NeuroVive Presents Preclinical Findings of NV556 in NASH Showing Confirmatory Anti-fibrotic Effects 2017-04-20 15:05
1